Covid-19 now endemic in India, say government scientists as cases decline

New Delhi: Covid-19 has become endemic in India, top scientists at the Department of Biotechnology (DBT) monitoring the virus have said, ruling out the risk of any severe fresh outbreak. The current situation, they noted, is marked by small, isolated episodes rather than large waves of infections.
This assessment is reflected in the steadily declining number of active cases. India's active caseload dropped to 5,012 on Sunday, down from 5,976 on Friday, according to official data. Two new deaths were recorded in the last 24 hours, taking the total fatalities this year to 112.
Scientists attribute the decline to high population immunity and the continuing mildness of the virus. The current spread is largely driven by Omicron sub-variants NB.1.8.1 and LF.7, which have so far remained less virulent.
'When transmission efficiency increases, the peak comes faster and the decline is also faster,' said Dr Raman Gangakhedkar, national chair at the Indian Council of Medical Research (ICMR) and former head scientist at the agency. 'Covid-19 has become endemic in India. The concerning part is that we don't want new infections, but the good news is that new variants over the last three years have remained mild or milder.'
He also noted that many infections now go undetected but still contribute to building antibody responses in the population, a natural form of immunization that limits severe illness.
The testing levels have declined, and comprehensive data on current infections remains limited.
'Presently, there is no very good record of the number of tests being done, and it needs to be done scientifically. But there are no significant adverse clinical symptoms to be concerned about,' one senior DBT scientist said.
Dr Rajeev Jayadevan, public health expert and past president of the Indian Medical Association (IMA), Cochin, said that Covid-19 is now behaving like a cyclical disease, with temporary immunity leading to periodic rises in cases. 'As the level of immunity in the population drops, the virus is able to infect more people and cases will naturally rise. However, due to past vaccination and exposure to the virus earlier, immune memory protects against severe disease and death,' he said. Vulnerable individuals, he added, should remain cautious, especially during periods of surge.
Jayadevan also pointed out that SARS-CoV-2 continues to evolve in response to the human immune system, leading to recurring infection cycles roughly every 6 to 12 months. 'The reported number of cases is always an underestimate because of limited testing,' he said. Influenza, which is also circulating, remains a significant contributor to disease burden, he added.
Earlier, Mint reported that a spike in cases during April was driven by the JN.1.16 sub-variant of Omicron. In May, most cases were linked to recombinant sub-lineages such as LF.7 and LP.8.1.2. As per government guidelines, all hospitalized Severe Acute Respiratory Illness (SARI) patients and 5% of Influenza Like Illness (ILI) cases continue to be tested for Covid-19. Positive SARI samples are routinely sent for genome sequencing.
The health ministry reported 1,197 recoveries in the past 24 hours, bringing total recoveries this year to 19,435. Authorities continue to advise precautions, including avoiding crowded places when unwell and following Covid-appropriate behaviour.
'In hospitals too, patient load has come down and most cases are now manageable at home,' said Dr Vikas Maurya, head of the respiratory department at Fortis Hospital, Shalimar Bagh.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

News18

33 minutes ago

• News18

All About The New COVID-19 Variant Causing 'Razor Blade' Sore Throats

Last Updated: The new variant called the NB.1.8.1 has been detected in the US among travellers coming in from Western Pacific nations, with a rising number of patients. The recent spike in coronavirus cases in certain parts of the world has been attributed to a new variant of the virus that caused a global health pandemic, nicknamed the 'razor blade throat" COVID. The variant is called the NB.1.8.1 or 'Nimbus' and causes painful sore throats among those who come into contact. The symptom has been discovered by scientists in India and the United Kingdom, apart from other parts of the world, according to various media outlets. Just when the world was beginning to move on from the horrors of the global health emergency, coronavirus has sprung back into news and discussions with a rising number of affected persons by the new variant. Fever, chills, cough, shortness of breath and loss of taste or smell are proven symptoms of any COVID variant, but Nimbus especially attacks one's throat. While health experts suggest there isn't a cause for major worries about this form of COVID, here is what you need to know about the variant responsible for the sudden spike in global cases. According to a statement dated May 28 by the World Health Organisation, the variant causing the 'razor blade throat' has been spreading primarily in the eastern Mediterranean, Southeast Asia and western Pacific regions. The new variant is responsible for nearly 11% of the global sequenced samples reported since May. In the United States, airport screening held in California, Washington state, Virginia and New York found travellers coming in from those regions affected by the new variant. The new variant is unlikely to cause any worse damage than other variants of the virus that emerged from China in December 2019. Even though Western Pacific countries have reported an increasing number of cases and persons hospitalised, the WHO says there is no proof to suggest the Nimbus variant comes with a disease and symptoms more dangerous than other variants. Likewise, the vaccines proven effective against those variants will help provide relief against NB.1.8.1 as well. The WHO has marked the public health risk from the new variant at a low level, designating it as a 'variant under monitoring" with current vaccinations remaining effective. Last month, Robert F Kennedy Jr announced that COVID-19 injection shots are no longer recommended for healthy children and women undergoing pregnancy. But public health experts raised an immediate question mark on the claim made by the US Health Secretary. First Published: June 22, 2025, 12:37 IST

Time of India

an hour ago

• Time of India

Maharashtra reports 37 new COVID-19 cases

Mumbai: Maharashtra recorded 37 new coronavirus positive cases on Saturday, taking its overall infection count since January this year to 2,318, the health department said. No fresh fatality linked to the disease has been reported since Thursday. Of the new cases, 19 are in Mumbai, seven in Pune, five in Nagpur, two in Thane city and one each in Panvel, Sangli city as well the district's rural parts, and Akola city, an official statement said. The health department has conducted 25,199 COVID-19 tests across the state since January this year, it said, adding a total of 1,962 patients have recovered so far. Mumbai has reported 942 infection cases this year, including 501 in June and 435 in May, it said. Thirty-two patients have succumbed to the infection in the state since January, of whom 31 had comorbidities and one was suffering from other diseases. PTI>

Business Standard

2 hours ago

• Business Standard

Flu shot must as winter viruses may trigger heart attack or stroke: Study

People who are particularly vulnerable to a heart attack or stroke triggered by a respiratory virus are those with more than one of those traditional risk factors, especially older people The Conversation Winter is here, along with cold days and the inevitable seasonal surge in respiratory viruses. But it's not only the sniffles we need to worry about. Heart attacks and strokes also tend to rise during the winter months. In new research out this week we show one reason why. Our study shows catching common respiratory viruses raises your short-term risk of a heart attack or stroke. In other words, common viruses, such as those that cause flu and Covid, can trigger them. Wait, viruses can trigger heart attacks? Traditional risk factors such as smoking, high cholesterol, high blood pressure, diabetes, obesity and lack of exercise are the main reasons for heart attacks and strokes. And rates of heart attacks and strokes can rise in winter for a number of reasons. Factors such as low temperature, less physical activity, more time spent indoors – perhaps with indoor air pollutants – can affect blood clotting and worsen the effects of traditional risk factors. But our new findings build on those from other researchers to show how respiratory viruses can also be a trigger. The theory is respiratory virus infections set off a heart attack or stroke, rather than directly cause them. If traditional risk factors are like dousing a house in petrol, the viral infection is like the matchstick that ignites the flame. For healthy, young people, a newer, well-kept house is unlikely to spontaneously combust. But an older or even abandoned house with faulty electric wiring needs just a spark to lead to a blaze. People who are particularly vulnerable to a heart attack or stroke triggered by a respiratory virus are those with more than one of those traditional risk factors, especially older people. What we did and what we found Our team conducted a meta-analysis (a study of existing studies) to see which respiratory viruses play a role in triggering heart attacks and strokes, and the strength of the link. This meant studying more than 11,000 scientific papers, spanning 40 years of research. Overall, the influenza virus and SARS-CoV-2 (the virus that causes Covid) were the main triggers. If you catch the flu, we found the risk of a heart attack goes up almost 5.4 times and a stroke by 4.7 times compared with not being infected. The danger zone is short – within the first few days or weeks – and tapers off with time after being infected. Catching Covid can also trigger heart attacks and strokes, but there haven't been enough studies to say exactly what the increased risk is. We also found an increased risk of heart attacks or strokes with other viruses, including respiratory syncytial virus (RSV), enterovirus and cytomegalovirus. But the links are not as strong, probably because these viruses are less commonly detected or tested for. What's going on? Over a person's lifetime, our bodies wear and tear and the inside wall of our blood vessels becomes rough. Fatty build-ups (plaques) stick easily to these rough areas, inevitably accumulating and causing tight spaces. Generally, blood can still pass through, and these build-ups don't cause issues. Think of this as dousing the house in petrol, but it's not yet alight. So how does a viral infection act like a matchstick to ignite the flame? Through a cascading process of inflammation. High levels of inflammation that follow a viral infection can crack open a plaque. The body activates blood clotting to fix the crack but this clot could inadvertently block a blood vessel completely, causing a heart attack or stroke. Some studies have found fragments of the Covid virus inside the blood clots that cause heart attacks – further evidence to back our findings. We don't know whether younger, healthier people are also at increased risk of a heart attack or stroke after infection with a respiratory virus. That's because people in the studies we analysed were almost always older adults with at least one of those traditional risk factors, so were already vulnerable. The bad news is we will all be vulnerable eventually, just by getting older. What can we do about it? The triggers we identified are mostly preventable by vaccination. There is good evidence from clinical trials the flu vaccine can reduce the risk of a heart attack or stroke, especially if someone already has heart problems. We aren't clear exactly how this works. But the theory is that avoiding common infections, or having less severe symptoms, reduces the chances of setting off the inflammatory chain reaction. Covid vaccination could also indirectly protect against heart attacks and strokes. But the evidence is still emerging. Heart attacks and strokes are among Australia's biggest killers. If vaccinations could help reduce even a small fraction of people having a heart attack or stroke, this could bring substantial benefit to their lives, the community, our stressed health system and the economy. What should I do? At-risk groups should get vaccinated against flu and Covid. Pregnant women, and people over 60 with medical problems, should receive RSV vaccination to reduce their risk of severe disease. So if you are older or have predisposing medical conditions, check Australia's National Immunisation Program to see if you are eligible for a free vaccine. For younger people, a healthy lifestyle with regular exercise and balanced diet will set you up for life. Consider checking your heart age (a measure of your risk of heart disease), getting an annual flu vaccine and discuss Covid boosters with your GP.